ROS1 Mutation Non-Small Cell Lung Cancer—access to Optimal Treatment and Outcomes

ecancermedicalscience - United Kingdom
doi 10.3332/ecancer.2019.900
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ecancer Global Foundation

Related search

ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2015English

P2.01-50 Thromboembolism in ROS1 Rearranged Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Erratum To: ROS1 Gene Rearrangement and Copy Number Gain in Non-Small Cell Lung Cancer

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2015English

Correction To: MiR-760 Suppresses Non-Small Cell Lung Cancer Proliferation and Metastasis by Targeting ROS1

Environmental Science and Pollution Research
MutagenesisEnvironmental ChemistryHealthMedicineToxicologyPollution
2018English

Prevalence of ROS1 Fusion in Chinese Patients With Non-Small Cell Lung Cancer

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2018English

KRAS Mutation, KRAS–LCS6 Polymorphism, and Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2010English

PS01.36: Blood-Based Mutation Testing in Non–Small Cell Lung Carcinoma Patients Supports Individualized and Optimal Treatment

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

P1.01-01 ROS1-Positive Non-Small Cell Lung Cancer: Real-World Data in Korea

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Detection of ROS1-positive Non-Small Cell Lung Cancer on Cytological Specimens Using Immunocytochemistry

Cancer cytopathology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy